Advaita Bioinformatics is a leader in the interpretation of high-throughput biomedical data including variant interpretation, pathway analysis, and disease subtype discovery. In a breakthrough in cancer diagnosis, a technology developed by a team of researchers from Wayne State University and [...]
Plymouth, MI (August 13, 2017 )– Advaita Bioinformatics, one of the most innovative companies in the field of Genomics, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant of $225,000 to conduct research and development [...]
Plymouth, MI (June 13, 2017) - Genetic analysis and variant interpretation has come a long way. However, to make this science a viable option for patient care, it is required for companies to make this data HIPAA compliant, easily readable, [...]
On February 17, 2017, we found out about Cloudbleed, a major leak of user data affecting several sites and services that use infrastructure provided by Cloudflare. As part of Advaita’s commitment to offering a HIPAA compliant secure informatics platform, we [...]
Advaita Bio's iPathwayGuide was chosen after a lengthy evaluation to be a side-wide solutions provider for the analysis of mRNA and protein expression data for all researchers attached to the National Cancer Institute (NCI). Its ease of use, advance analytic [...]
Download Poster (PDF)
Advaita Bioinformatics has been recognized as one of the 2016 “Michigan 50 Companies to Watch,” an awards program presented by Michigan Celebrates Small Business. Advaita will be honored at an awards ceremony during the twelfth annual Michigan Celebrates Small Business [...]
Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced an exclusive reseller agreement with Advaita Bioinformatics, a leader in the development of bioinformatic solutions for multi-omic biological data, that will allow SCIEX to sell Advaita [...]
Advaita Bioinformatics (Advaita) announced today that it has entered into an exclusive partnership with Riken Genesis Co. Ltd., (Riken-Genesis) for the promotion and sale of Advaita’s flagship product, iPathwayGuide in Japan. Under the agreement, iPathwayGuide will be a featured informatics [...]
SCIEX a global leader in life science analytical technologies today announced collaborators in the OneOmics™ project an exclusive partnership between Illumina and SCIEX that integrates SWATH™ Acquisition based next-generation proteomics (NGP) and next-generation sequencing (NGS) data on the BaseSpace® cloud [...]
Plymouth, MI - February 4, 2015 – Advaita Bioinformatics (Advaita) announced today that it has entered into a partnership with LifeMap Sciences, Inc. (LifeMap), a subsidiary of BioTime, Inc. (NYSE MKT:BTX), for the promotion and sale of Advaita’s flagship product, [...]
Plymouth, MI - September 18, 2014 – Advaita Bioinformatics announced today that it has secured a $125,000 matching grant from the Michigan Emerging Technology Fund (ETF) administered through the Michigan Small Business Development Center (MI-SBDC). The grant is a 1:1 [...]
Advaita scored nearly $2 million in seed capital this month after it landed the second phase of an SBIR grant to develop its bioinformatics software. "It will allow us to continue development of our software tools and our products for [...]
Today, Advaita Bioinformatics received a Notice of Award from the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (NIGMS) for a Phase II Small Business Investigational Research (SBIR) grant worth $1.76M over three years. Advaita is a [...]